Rare diseases have long been a challenge for the medical community, affecting millions of people worldwide. These diseases are often […]
Biotechnology’s Impact on Rare Diseases: A New Hope? Read Post »
Annual Drug Patent Expirations for ZORYVE Zoryve is a drug marketed by Arcutis and is included in two NDAs. It […]
Source
Annual Drug Patent Expirations for WEGOVY Wegovy is a drug marketed by Novo and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for RETEVMO Retevmo is a drug marketed by Loxo Oncol Eli Lilly and is included in […]
Source
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
This chart shows the drugs with the most patents in Chile. Patents must be filed in each country (or, in […]
Source
Which pharmaceutical drugs have the most drug patents in Chile? Read Post »
In recent years, the pharmaceutical industry has witnessed a significant shift towards natural excipients, driven by increasing consumer demand for safer, more sustainable products. These plant-derived ingredients are transforming drug formulation and …
Top 5 Natural Excipients Revolutionizing Pharmaceutical Formulations Read Post »
Water management is a critical issue globally, with the increasing demand for clean water and the need to address the
This is an example from the DrugPatentWatch AI Research Assistant, which is available with DrugPatentWatch subscriptions. The DrugPatentWatch AI Research […]
Source
Viagra’s Resilience in the Face of Generic Competition: A Pharmaceutical Market Analysis Read Post »
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd […]
Source
New tentative approval for Alembic drug dabigatran etexilate mesylate Read Post »
Get new actionable insights and updates from BiotechBlog
